Good morning from Paul & Graham!
Weekend Podcast - for anyone interested. I've no idea how many listeners these are getting! It went up on Sunday morning this weekend, as I was out on the razzle on Friday night in Bournemouth, so nothing much got done the next day.
Agenda -
Paul's Section:
Joules (LON:JOUL) (I hold) - good news that a new CEO has been found. I recap on the various issues that have made this share such a disaster in the last year. So it all hinges now on shoring up the balance sheet, and swift action needed from the new CEO to sort out its problematic supply chain & excessive inventories. Could be a good turnaround, but risks remain.
Gusbourne (LON:GUS) 67p up 5% at 08:45 (mkt cap £41m) [no section below] - I’ll keep this brief, as GUS shares are illiquid, given that Lord Ashcroft owns 66% of it. H1 (to 6/2022) revenues are small at £3.0m, but that’s up 108% Y-on-Y. Asset-backed borrowing facility increases from £10.5m to £16.5m, for 5 years, “at a competitive rate”, 2.5% over BoE base rate. GUS is spending £1.6m buying 137 acres of adjoining land from one of its own Directors. Vines will be planted in May 2024, so it’s long-term in nature. I reviewed GUS’s last accounts here in June, and was unimpressed. On the same day I also looked at fellow English wine maker, Chapel Down (OFEX:CDGP) and think that looks a far better financial bet, if you have to own one of these shares CDGP is clearly the better investment proposition - bigger, already profitable, and with a decent balance sheet.
Graham's Section:
Portmeirion (LON:PMP) (£56m) (pre-market) - a very small acquisition for Portmeirion but the new brand “Aromaworks” could have significant long-term growth potential in the hands of Portmeirion (time will tell). I use the opportunity to discuss why companies in administration often make for spectacular investment opportunities for the people who buy up the assets or who buy the debt and wipe out existing equity holders. We can’t take part in these deals ourselves, but we can look for listed companies who are able to do it, and share in the rewards.
Treatt (LON:TET) (£340m) - there’s a major profit warning from this provider of extracts and ingredients. The macro headwinds…